Abstract:Background Sorbin and SH3 domain containing 2 (Sorbs2) protein is a cytoskeletal adaptor with an emerging role in cardiac biology and disease; yet, its potential relevance to adult‐onset cardiomyopathies remains underexplored. Sorbs2 global knockout mice display lethal arrhythmogenic cardiomyopathy; however, the causative mechanisms remain unclear. Herein, we examine Sorbs2 dysregulation in heart failure, characterize novel Sorbs2 cardiomyocyte‐specific knockout mice (Sorbs2‐cKO), and explore associations between Sorbs2 genetic variations and human cardiovascular disease. Methods and Results Bioinformatic analyses show myocardial Sorbs2 mRNA is consistently upregulated in humans with adult‐onset cardiomyopathies and in heart failure models. We generated Sorbs2‐cKO mice and report that they develop progressive systolic dysfunction and enlarged cardiac chambers, and they die with congestive heart failure at about 1 year old. After 3 months, Sorbs2‐cKO mice begin to show atrial enlargement and P‐wave anomalies, without dysregulation of action potential–associated ion channel and gap junction protein expressions. After 6 months, Sorbs2‐cKO mice exhibit impaired contractility in dobutamine‐treated hearts and skinned myofibers, without dysregulation of contractile protein expressions. From our comprehensive survey of potential mechanisms, we found that within 4 months, Sorbs2‐cKO hearts have defective microtubule polymerization and compensatory upregulation of structural cytoskeletal and adapter proteins, suggesting that this early intracellular structural remodeling is responsible for contractile dysfunction. Finally, we identified genetic variants that associate with decreased Sorbs2 expression and human cardiac phenotypes, including conduction abnormalities, atrial enlargement, and dilated cardiomyopathy, consistent with Sorbs2‐cKO mice phenotypes. Conclusions Our studies show that Sorbs2 is essential for maintaining structural integrity in cardiomyocytes, likely through strengthening the interactions between microtubules and other cytoskeletal proteins at cross‐link sites. Nonstandard Abbreviations and Acronyms ARVC arrhythmogenic right ventricular cardiomyopathy Cx43 connexin 43 DCM dilated cardiomyopathy ICD intercalated disc NRCM neonatal rat cardiomyocyte Sorbs2‐cKO Sorbs2 cardiomyocyte‐specific knockout mice TAC transverse aortic constriction WT wild type αMHC‐Cre α‐myosin heavy chain promoter driving Cre recombinase Clinical Perspective What Is New? Using available RNA expression data sets, we show that Sorbs2 is consistently dysregulated in human patients and experimental models of ischemic, idiopathic, and hypertrophic cardiomyopathy, and that myocardial Sorbs2 isoforms lack the RNA‐binding domain, which has been previously proposed to regulate cardiomyocyte biology. In mice with cardiomyocyte‐specific deletion of Sorbs2, we find early defects in myocardial microtubule polymerization, left atrial enlargement, and P‐wave anomalies, with a subsequent progression toward a dilated cardiomyopathy phenotype, consisting of systolic dysfunction, chamber dilation, and congestive heart failure. Using genome‐ and phenome‐wide association data, we identify genetic variants in SORBS genes that are associated with cardiovascular‐related clinical phenotypes, with notable instances that are consistent with Sorbs2 cardiomyocyte‐specific knockout mice phenotypes, including P‐wave alterations, left atrial enlargement, and dilated cardiomyopathy. What Are the Clinical Implications? When integrated with other previous work, these findings show that cardiomyocyte‐specific deletion of Sorbs2 is only partially responsible for lethal arrhythmogenic cardiomyopathy observed in global Sorbs2‐KO mice, suggesting that other cell types contributing to cardiovascular functions m -Abstract Truncated-

Expression of a sorcin missense mutation in the heart modulates excitation-contraction coupling

Overexpression of sorcin improves cardiac excitation-contraction coupling in normal and failing ventricular cardiomyocytes

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

Knockout of Sorbs2 in Cardiomyocytes Leads to Dilated Cardiomyopathy in Mice

Regulation of Cardiac Excitation-Contraction Coupling by Sorcin, a Novel Modulator of Ryanodine Receptors

Knockout of Sorbin And SH3 Domain Containing 2 (Sorbs2) in Cardiomyocytes Leads to Dilated Cardiomyopathy in Mice

Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases

Cardiac Contractility Modulation Electrical Signals Normalize Expression of the Excitation-Contraction Coupling Proteins Presenillin-2 and Sorcin in Left Ventricular Myocardium of Dogs with Chronic Heart Failure

Knockout of SORBS2 Protein Disrupts the Structural Integrity of Intercalated Disc and Manifests Features of Arrhythmogenic Cardiomyopathy.

Deregulated Ca2+ cycling underlies the development of arrhythmia and heart disease due to mutant obscurin

Soluble resistance-related calcium-binding protein participates in multiple diseases via protein-protein interactions

Differential splicing patterns of L-type calcium channel Cav1.2 subunit in hearts of Spontaneously Hypertensive Rats and Wistar Kyoto Rats.

Cardiac Hypertrophy and Arrhythmia in Mice Induced by a Mutation in Ryanodine Receptor 2

Corin Mutation R539C from Hypertensive Patients Impairs Zymogen Activation and Generates an Inactive Alternative Ectodomain Fragment

SERCA2 Haploinsufficiency in a Mouse Model of Darier Disease Causes a Selective Predisposition to Heart Failure

SORBS2 is a susceptibility gene to arrhythmogenic right ventricular cardiomyopathy

LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice

A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study

Conditional Up-Regulation of SERCA2a Exacerbates RyR2-Dependent Ventricular and Atrial Arrhythmias

SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis

Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca<SUP>2+</SUP> sensitivity